The companies said that the agreement includes patents relating to real-time polymerase chain reaction methods and instrumentation, including the 5’ Nuclease process and the use of SYBR Green I in PCR reactions.
The intellectual property covered by the agreement has been instrumental in expanding applications in molecular biology, and has contributed toward each company’s ability as a provider of solutions for DNA analysis.
Randy Rasmussen, president of Idaho Technology, said: “This agreement demonstrates both companies’ commitments to advancing quality research in the applied and life science fields. It also enables innovation in a more open environment that is good for business and ultimately benefits customers.”